EP
MREO

Eversept Partners’s Mereo BioPharma MREO Stock Holding History

Eversept Partners’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-777,890
Closed -$2.72M – 68
2024
Q4 		$2.72M Hold
777,890
– – 0.24% 52
2024
Q3 		$3.2M Buy
777,890
+281,719
+57% +$1.17M 0.22% 52
2024
Q2 		$1.79M Buy
+496,171
New +$1.61M 0.12% 66
2022
Q2 		– Sell
-370,170
Closed -$415K – 94
2022
Q1 		$415K Buy
370,170
+110,700
+43% +$143K 0.03% 81
2021
Q4 		$415K Sell
259,470
-640,099
-71% -$1.28M 0.03% 102
2021
Q3 		$2.18M Buy
+899,569
New +$2.38M 0.15% 74

Other funds holding MREO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

Eversept Partners's MREO Position: Q1 2025 in Review

Eversept Partners sold out of Mereo BioPharma (MREO) in Q1 2025, closing a stake of 777,890 shares — an estimated $2.72M sold.

Eversept Partners first reported a position in MREO in Q3 2021 and held it in 6 quarters. The position peaked at $3.2M in Q3 2024. 90 funds tracked by Wall St. Rank hold MREO as of Q1 2025.

  • Eversept Partners reported no remaining Mereo BioPharma position as of Q1 2025 after selling out during the quarter.
  • Eversept Partners sold 777,890 Mereo BioPharma shares in Q1 2025, an estimated $2.72M.
  • Eversept Partners first reported a position in Mereo BioPharma in Q3 2021 and held it in 6 quarters.
  • Eversept Partners's Mereo BioPharma position peaked at $3.2M in Q3 2024.
  • 90 funds tracked by Wall St. Rank held Mereo BioPharma as of Q1 2025.

Based on Eversept Partners's 13F filing for Q1 2025, filed 15 May 2025.